背景:基于Web的学习活动是针对医疗保健专业人员(HCP)的继续医学教育(CME)的关键组成部分。然而,针对早期乳腺癌(EBC)的基于网络的教育干预措施的发表结果有限.
目的:本研究旨在客观评估知识,能力,以及参加2次以EBC为重点的CME活动后HCP之间的表现,并确定剩余的教育差距。
方法:我们开发了2项CME认可的基于网络的教育活动,以解决高风险的EBC,包括整合共同决策以优化患者护理(touchMDT)和分层以早期识别高危患者和新的治疗策略(touchPANELDISCUSSION)。知识,能力,使用自我报告的问卷和对从患者记录中提取的匿名数据的分析,根据扩展的结果框架(1-5级)评估活动前后的绩效.
结果:活动启动六个月后,7047和8989HCP参与者参与touchMDT和touchPANEL讨论,分别。touchMDT的总体满意度为82%(25分总分20.6分),touchPANELDISUSSION的总体满意度为88%(25分总分21.9分)。对于知识和能力的评估(活动前50名受访者和活动后50名学习者),从活动前到活动后,正确回答的问题的平均数量显着增加(touchMDT:中位数4.0,IQR3.0-5.0至中位数5.5,IQR4.0-7.0;平均值4.00,SD1.39至平均值5.30,SD1.56和touchPANELDISUSSION:中位数4.0,IQR4.0-5.0至中位数6.0,IQR5.0-7.0;平均值4.32,SD1.30至5.88,SD在两项活动的综合分析中观察到自我报告表现的显着改善(活动前50名受访者和活动后50名学习者)(中位数3.0,IQR2.0-3.0至中位数4.0,IQR3.0-5.0;平均值2.82,SD1.08至平均值4.16,SD1.45;P<.001)。患者记录分析(活动前50名受访者,活动后50名学习者)显示,HCP使用了一系列措施来确定EBC复发风险,并且在活动前后使用的辅助治疗没有显着差异(对于Ki-67<20%和Ki-67≥20%的肿瘤,P=.97和P>.99,分别)。其余的教育差距包括在临床实践中实施共同决策的策略以及使用遗传和生物标志物测试来指导治疗选择。
结论:简介,基于网络的CME在EBC上的活动与HCP知识的改善有关,能力,和自我报告的性能,并可以帮助识别未满足的需求,以告知未来的CME活动的设计。
BACKGROUND: Web-based learning activities are key components of continuing medical education (CME) for health care professionals (HCPs). However, the published outcomes of web-based educational interventions for early breast cancer (EBC) are limited.
OBJECTIVE: This study aims to objectively assess knowledge, competence, and performance among HCPs following participation in 2 EBC-focused CME activities and to identify the remaining educational gaps.
METHODS: We developed 2 CME-accredited web-based educational activities addressing high-risk EBC, including integration of shared decision-making to optimize patient care (touchMDT) and stratification for early identification of high-risk patients and novel treatment strategies (touchPANEL DISCUSSION). Knowledge, competence, and performance were assessed before and after the activities against an expanded outcomes framework (levels 1-5) using self-reported questionnaires and an analysis of anonymized data extracted from patient records.
RESULTS: Six months after the launch of the activity, 7047 and 8989 HCP participants engaged with touchMDT and touchPANEL DISCUSSION, respectively. The overall satisfaction was 82% (a total score of 20.6 out of 25) for the touchMDT and 88% (a total score of 21.9 out of 25) for the touchPANEL DISCUSSION. For the evaluation of knowledge and competence (50 respondents before the activity and 50 learners after the activity), there was a significant increase in the mean number of correctly answered questions from pre- to postactivity (touchMDT: median 4.0, IQR 3.0-5.0 to median 5.5, IQR 4.0-7.0; mean 4.00, SD 1.39 to mean 5.30, SD 1.56 and touchPANEL DISCUSSION: median 4.0, IQR 4.0-5.0 to median 6.0, IQR 5.0-7.0; mean 4.32, SD 1.30 to mean 5.88, SD 1.49; both P<.001). A significant improvement in self-reported performance (50 respondents before the activity and 50 learners after the activity) was observed in a combined analysis of both activities (median 3.0, IQR 2.0-3.0 to median 4.0, IQR 3.0-5.0; mean 2.82, SD 1.08 to mean 4.16, SD 1.45; P<.001). Patient record analysis (50 respondents before the activity and 50 learners after the activity) showed that the HCPs used a range of measures to determine EBC recurrence risk and revealed no significant differences in adjuvant therapies used before and after the activity (P=.97 and P>.99 for Ki-67 <20% and Ki-67 ≥20% tumors, respectively). The remaining educational gaps included strategies for implementing shared decision-making in clinical practice and the use of genetic and biomarker testing to guide treatment selection.
CONCLUSIONS: Brief, web-based CME activities on EBC were associated with an improvement in HCP knowledge, competence, and self-reported performance and can help identify unmet needs to inform the design of future CME activities.